Profile

Perry Shen, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

191 Ratings
14 Comments
 

Perry Shen, M.D.

Program Director, Surgical Sciences-Oncology
Professor, General Surgery

Clinical Interests

Sarcoma, Hepatobiliary Surgery, Minimally Invasive Liver and Pancreatic Resection, Gastrointestinal Oncology Surgery, Peritoneal Surface Malignancies, Pancreatic Surgery, Melanoma

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4276
Department: 336-716-0545

Email: pshen@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.A., University of California-Irvine, 1988
  • B.S., University of California-Irvine, 1988
  • M.D., University of Southern California Sch of Medicine, 1992
  • Internship, Obstetrics & Gynecology, J Hopkins-Balti Cty Hosps, 1993
  • Residency, Surgery, U Southern Calif Affil Hosps, 1998
  • Fellowship, John Wayne Cancer Institute, 2000

Board Certifications

  • American Board of Surgery, Surgery

Memberships

  • Am Assn Of Cancer Research
  • North Carolina Medical Assn
  • North Carolina Surgical Assn
  • Soc for Sur Of Alimentary Trac
  • Soc Of Surgical Oncology
  • Southeastern Surgical Congress
  • Southern Surgical Society
  • Society of Graduate Surgeons
  • Am Hepato-Pancreato-Biliary
  • Am Coll Of Surgeons
  • Am Medical Assn
  • Am Soc of Clinical Oncology
  • Assn Of Academic Surgery
  • Forsyth-Davie-Stokes Medical S

NPI Number

  • 1417932575
Perry Shen, M.D.

Doctor Rating

4.6 out of 5

191 Ratings
14 Comments
 

Perry Shen, M.D.

Program Director, Surgical Sciences-Oncology
Professor, General Surgery

Research Interests

Peritoneal Neoplasms; Hyperthermia, Induced; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Liver Neoplasms
More »

Contact Information

Academic: 336-716-0545 | Department: 336-716-0545

Email: pshen@wakehealth.edu

Media Medical Expert »

Recent Publications

Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Doud AN, Levine EA, Fino NF, Stewart JH, Shen P, Votanopoulos KI.. Ann Surg Oncol. 2016;23(2):503-510.

Conditional survival after cytoreductive surgery with heated intraperitoneal chemotherapy for low- and high-grade appendiceal primaries. Mogal HD, Levine EA, Russell G, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2016;23(2):534-538.

Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement. Mogal HD, Levine EA, Fino NF, Obiora C, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2016;23(5):1486-1495.

Optimal prognostic lymph node staging system for gallbladder adenocarcinoma: a multi-institutional study [abstract]. Amini N, Kim Y, Wilson A, Georgios GA, Ethun CG, Maithel SK, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Pawlik TM.. Ann Surg Oncol. 2016;23(Suppl 1):S12.

Conditional survival probability of long-term survival after resection of hilar cholangiocarcinoma [abstract]. Buettner S, Margonis G, Kim Y, Ethun CG, Maithel SK, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Pawlik TM.. Ann Surg Oncol. 2016;23(Suppl 1):S107.

A reappraisal of staging laparoscopy in three subtypes of cholangiocarcinoma: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Davidson JT, Jin L, Krasnick BA, Ethun CG, Pawlik TM, Poultsides GA, Tran TB, Idrees K, Isom CA, Weber S, Salem AI, Hawkins W, Strasberg S, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Fields RC.. Ann Surg Oncol. 2016;23(Suppl 1):S9.

A novel pathology-based preoperative risk score to predict distant and locoregional residual disease and survival for incidentally discovered gallbladder cancer: a 10-institution study from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Cardona K, Maithel SK.. Ann Surg Oncol. 2016;23(Suppl 1):S11.

The optimal time-interval to re-resection for incidentally discovered gallbladder cancer: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Vitiello G, Kooby DA, Maithel SK.. Ann Surg Oncol. 2016;23(Suppl 1):S104.

The effect of postoperative morbidity on long-term survival after curative resection for extrahepatic biliary tumors: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Jin L, Krasnick BA, Davidson JT, Ethun CG, Pawlik TM, Poultsides GA, Tran TB, Idrees K, Isom CA, Weber S, Salem AI, Hawkins W, Strasberg S, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Fields RC.. Ann Surg Oncol. 2016;23(Suppl 1):S117.

Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis [abstract]. Kim Y, Amini N, Georgios GA, Wilson A, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Cardona K, Maithel SK, Pawlik TM.. Ann Surg Oncol. 2016;23(Suppl 1):S12.

Curative resection for hilar cholangiocarcinoma: does adjuvant therapy impact overall survival? A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Krasnick BA, Jin L, Davidson JT, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Isom CA, Weber S, Salem AI, Hawkins W, Strasberg S, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Fields RC.. Ann Surg Oncol. 2016;23(Suppl 1):S113.

Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: a multi-institutional analysis [abstract]. Mogal H, Dodson R, Fino N, Ethun CG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Shen P.. Ann Surg Oncol. 2016;23(Suppl 1):S113.

Rates and patterns of recurrence following complete resection of hilar cholangiocarcinoma: results from the US Extrahepatic Biliary Consortium [abstract]. Mogal H, O'Connor S, Fino N, Ethun CG, Pawlik TM, Poultsides GA, Tran TB, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Shen P.. Ann Surg Oncol. 2016;23(Suppl 1):S108.

Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? [abstract]. Tran TB, Norton JA, Ethun CG, Pawlik TM, Buettner S, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA.. Ann Surg Oncol. 2016;23(Suppl 1):S116-S117.

Association of survival, postoperative morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using quality of life assessments [abstract]. Dodson RM, Mogal H, Russell G, Duckworth KE, Votanopoulos K, Shen P, Levine EA, McQuellon RP.. Ann Surg Oncol. 2016;23(Suppl 1):S35.

Prognostic molecular subtypes of low-grade cancer of the appendix. Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, Ruiz J, D'Agostino R, Shen P, Miller LD.. J Am Coll Surg. 2016;222(4):493-503.

Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. Mogal H, Chouliaras K, Levine EA, Shen P, Votanopoulos KI.. J Gastrointest Oncol. 2016;7(1):129-142.

Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Cummins KA, Russell GB, Votanopoulos KI, Shen P, Stewart JH, Levine EA.. J Gastrointest Oncol. 2016;7(1):3-9.

Use of a novel through-the-needle biopsy forceps in endoscopic ultrasound. Shakhatreh MH, Naini SR, Brijbassie AA, Grider DJ, Shen P, Yeaton P.. Endosc Int Open. 2016;4(4):E439-E442.

Prognostic implications of lymph node status for patients with gallbladder cancer: a multi-institutional study. Amini N, Kim Y, Wilson A, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.. Ann Surg Oncol. 2016;23(9):3016-3023.

Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. Bagante F, Tran T, Spolverato G, Ruzzenente A, Buttner S, Ethun CG, Groot Koerkamp B, Conci S, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Vitiello G, IJzermans JN,.. J Am Coll Surg. 2016;222(5):750-759.e2.

Assessing trends in palliative surgery for extrahepatic biliary malignancies: a 15-year multicenter study. Buettner S, Wilson A, Margonis GA, Gani F, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.. J Gastrointest Surg. 2016;20(8):1444-1452.

Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis. Kim Y, Amini N, Wilson A, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK, Pawlik TM.. Ann Surg Oncol. 2016;23(9):2998-3008.

Conditional probability of long-term survival after resection of hilar cholangiocarcinoma. Buettner S, Margonis GA, Kim Y, Gani F, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.. HPB (Oxford). 2016;18(6):510-517.

Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. Gani F, Buettner S, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.. J Surg Oncol. 2016;114(2):176-180.

Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for Clinical Trials in Oncology Trial A021101. Katz MH, Shi Q, Ahmad SA, Herman JM, Marsh RW, Collisson E, Schwartz L, Frankel W, Martin R, Conway W, Truty M, Kindler H, Lowy AM, Bekaii-Saab T, Philip P, Talamonti M, Cardin D, LoConte N, Shen P, Hoffman JP, Venook AP.. JAMA Surg. 2016;():e161137.

Optimal prognostic lymph node staging system for gallbladder adenocarcinoma: a multi-institutional study [abstract]. Amini N, Kim Y, Wilson A, Ethun CG, Maithel SK, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Weber SM, Salem AAF, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Hatzaras I, Shenoy R, Pawlik TM.. J Clin Oncol. 2016;34(4 Suppl):364.

Conditional survival probability of long-term survival after resection of peri-hilar cholangiocarcinoma [abstract]. Buettner S, Ethun CG, Maithel SK, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem AI, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Pawlik TM.. J Clin Oncol. 2016;34(4 Suppl):212.

A comparison of prognostic schemes for perihilar cholangiocarcinoma. Buettner S, van Vugt JL, Gani F, Groot Koerkamp B, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R,.. J Gastrointest Surg. 2016;():.

A reappraisal of staging laparoscopy in three subtypes of cholangiocarcinoma: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Davidson J, Jin L, Krasnick B, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Isom CA, Weber SM, Salem AI, Hawkins WG, Strasberg SM, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Maithel SK, Fields RC.. J Clin Oncol. 2016;34(4 Suppl):226.

A novel pathology-based preoperative risk score to predict distant and locoregional residual disease and survival for incidentally discovered gallbladder cancer: a 10-institution study from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ethun CG, Postlewait LM, Pawlik TM, Buettner S, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber SM, Salem AL, Scoggins CR, Shen P, Mogal H, Schmidt CR Beal EW, Hatzaras I, Shenoy R, Maithel SK.. J Clin Oncol. 2016;34(4 Suppl):202.

The optimal time-interval to re-resection for incidentally discovered gallbladder cancer: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ethun CG, Postlewait LM, Pawlik TM, Buettner S, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber SM, Salem AI, Scoggins CR, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK.. J Clin Oncol. 2016;34(4 Suppl):201.

The effect of postoperative morbidity on long-term survival after curative resection for extra-hepatic biliary tumors: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Jin LD, Krasnick B, Davidson J, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Isom CA, Weber SM, Salem AI, Scoggins CR, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Maithel SK, Fields RC.. J Clin Oncol. 2016;34(4 Suppl):435.

Impact of chemotherapy and external beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis [abstract]. Kim Y, Amini N, Wilson A, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Weber SM, Salem AI, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.. J Clin Oncol. 2016;34(4 Suppl):387.

Curative resection for hilar cholangiocarcinoma: does adjuvant therapy impact overall survival? A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Krasnick B, Jin L, Davidson J, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Isom CA, Weber SM, Salem AI, Hawkins WG, Strasberg SM, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Maithel SK, Fields RC.. J Clin Oncol. 2016;34(4 Suppl):388.

Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: a multi-institutional analysis [abstract]. Mogal H, Dodson R, Fino N, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Fields RC, Jin LD, Weber SM, Salem AI, Martin RCG, Scoggins CR, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Shen P.. J Clin Oncol. 2016;34(4 Suppl):326.

Rates and patterns of recurrence following complete resection of Hilar cholangiocarcinoma: results from the US Extrahepatic Biliary Consortium [abstract]. Mogal H, O'Connor S, Fino N, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin LD, Weber SM, Salem AI, Martin RCG, Scoggins CR, Schmidt CR, Beal EW, Hatzaras I, Maithel SK, Shen P.. J Clin Oncol. 2016;34(4 Suppl):324.

Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? [abstract]. Tran T, Ethun CG, Pawlik TM, Buettner S, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem AI, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA.. J Clin Oncol. 2016;34(4 Suppl):336.

Palliative treatment in extrahepatic biliary malignancies: a multi-institutional cohort [abstract]. Wilson A, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem AI, Martin RCG, Scoggins CR, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.. J Clin Oncol. 2016;34(4 Suppl):456.

Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2015;22(5):1645-1650.

Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2015;22(5):1634-1638.

Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA.. Ann Surg Oncol. 2015;22(4):1274-1279.

Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Randle RW, Ahmed S, Levine EA, Fino NF, Swett KR, Stewart JH, Shen P, Votanopoulos KI.. J Surg Oncol. 2015;111(6):740-745.

Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH IV, Shen P, Levine EA, Votanopoulos KI.. J Surg Res. 2015;196(2):229-234.

Thoracic epidural versus intravenous patient controlled analgesia in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy [abstract]. Slocum K, Adams L, Shen P, Griffith K, Allen S, Fino N, DeRoche A.. In: Abstracts of the 14th Annual ASRA Pain Medicine Meeting; 2015 May 14-16; Las Vegas (NV). 2015;():A530.

Biliary duplication cyst. Randle RW, Qasem SA, Shen P.. Am Surg. 2015;81(7):E291-E293.

Comparison of observed to predicted outcomes using the ACS NSQIP universal risk calculator in patients undergoing pancreatoduodenectomy [abstract]. Mogal H, Fino N, Clark CJ, Shen P.. Ann Surg Oncol. 2015;22(Suppl 1):S133.

Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes. Shen P, Fino N, Levine EA, Eversole P, Clark C.. HPB (Oxford). 2015;17(12):1066-1073.

Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing hepatectomy [abstract]. Allen S, DeRoche A, Adams L, Slocum K, Fitzgerald N, Clark CJ, Shen P.. Ann Surg Oncol. 2015;22(Suppl 1):S102.

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI.. J Am Coll Surg. 2014;218(4):573-585.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, General Surgery

Clinical Interests

Sarcoma, Hepatobiliary Surgery, Minimally Invasive Liver and Pancreatic Resection, Gastrointestinal Oncology Surgery, Peritoneal Surface Malignancies, Pancreatic Surgery, Melanoma
Perry Shen, M.D.

Perry Shen, M.D.

Program Director, Surgical Sciences-Oncology
Professor, General Surgery

Doctor Rating

4.6 out of 5

Perry Shen, M.D.191 Ratings
14 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.6



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

4/13/2016

I am very grateful to Wake Forest Baptist Hospital and Dr. Perry Shen for the care they have given me for the past 4-1/2 years.

3/28/2016

Doctor seemed to care about my situation and wants to do what is best for me.

3/22/2016

Great.

1/6/2016

Good.

1/1/2016

Dr. Shen is a great dotor

12/31/2015

I love Dr. Shen

12/20/2015

Dr. Shen sat down with us and took time to explain my medical condition and surgery needed. He was very through explaining the surgery options. He answered all our questions, concerns in detail and we left knowing what to expect. We are very thankful for Dr. Shen's decision to remove the tumor rather than just a biopsy and the positive outcome from the surgery.

12/15/2015

I am trusting Dr. Shen with my level 4 cancer. He is going to do a HIPEC procedure -- only choice to save my life. He and I are going for another 10 years of productive life.

11/17/2015

always willing to answer all ques

11/2/2015

Dr Shen was very caring and thorough

10/28/2015

communication seem to be poor between my local doctor and wakeforest

10/27/2015

Dr Shen is certainly qualified and I have full confidence in him.

9/25/2015

I have recommended *Dr. Shen to several people & they have come to the hospital.

9/4/2015

Would recommend *Dr. Shen and his staff to anyone they are awesome.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.